Antecedent Hypoglycemia Impairs Autonomic Cardiovascular Function
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 37 of the 37 references it cites were found in a registry or an index.
Abstract
OBJECTIVE— Glycemic control decreases the incidence and progression of diabetic complications but increases the incidence of hypoglycemia. Hypoglycemia can impair hormonal and autonomic responses to subsequent hypoglycemia. Intensive glycemic control may increase mortality in individuals with type 2 diabetes at high risk for cardiovascular complications. We tested the hypothesis that prior exposure to hypoglycemia leads to impaired cardiovascular autonomic function. RESEARCH DESIGN AND METHODS— Twenty healthy subjects (age 28 ± 2 years; 10 men) participated in two 3-day inpatient visits, separated by 1–3 months. Autonomic testing was performed on days 1 and 3 to measure sympathetic, parasympathetic, and baroreflex function. A 2-h hyperinsulinemic [hypoglycemic (2.8 mmol/l) or euglycemic (5.0 mmol/l)] clamp was performed in the morning and in the afternoon of day 2. RESULTS— Comparison of the day 3 autonomic measurements demonstrated that antecedent hypoglycemia leads to 1) reduced baroreflex sensitivity (16.7 ± 1.8 vs. 13.8 ± 1.4 ms/mmHg, P = 0.03); 2) decreased muscle sympathetic nerve activity response to transient nitroprusside-induced hypotension (53.3 ± 3.7 vs. 40.1 ± 2.7 bursts/min, P < 0.01); and 3) reduced (P < 0.001) plasma norepinephrine response to lower body negative pressure (3.0 ± 0.3 vs. 2.0 ± 0.2 nmol/l at −40 mmHg). CONCLUSIONS— Baroreflex sensitivity and the sympathetic response to hypotensive stress are attenuated after antecedent hypoglycemia. Because impaired autonomic function, including decreased cardiac vagal baroreflex sensitivity, may contribute directly to mortality in diabetes and cardiovascular disease, our findings raise new concerns regarding the consequences of hypoglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other adverse physiologic effects of hypoglycemia such as attenuation of baroreflex sensitivity (12) and hyperalgesia (37) persist even after resolution of hypoglycemia.”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“and in autonomic cardiovascular homeostatic measures such as baroreflex sensitivity (12, 13)”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“whereas impaired baroreflex sensitivity persists at least 16 hours after recovery from hypoglycemia (12)”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“Further, antecedent hypoglycemia as compared to euglycemia resulted in a blunted plasma norepinephrine response and increased predisposition to syncope in response to a graded simulated orthostatic stress induced by lower body negative pressure when individuals were euglycemic (Fig. 6) (Adler et al., 2009).”
From Stress, hypoglycemia, and the autonomic nervous system (2022) · cites this paper as Adler et al., 2009
In the citing paper
“Taken together, with studies that show that hypoglycemia-mediated attenuation of cardiac-vagal baroreflex function occurs during hypoglycemia (Rao et al., 2016), these results suggest that attenuation of cardiac-vagal baroreflex function begins during hypoglycemia and persists for at least 16 h after restoration of euglycemia (Rao et al., 2016; Adler et al., 2009).”
From Stress, hypoglycemia, and the autonomic nervous system (2022) · cites this paper as Adler et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 1×
“3 Control of blood glucose is the cornerstone of diabetes management as glycemic control decreases the incidence and progression of diabetic microvascular (1-4) and, in some studies, macrovascular complications (2;5).”
BackgroundKleiger, R. E., Miller, J. P., Bigger, J. T., & Moss, A. J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90795-8 · Cited by 3,995
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Diabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 1×
“Autonomic neuropathy is a predictor of increased mortality in many diabetic cohort studies (10,11).”
BackgroundYasuma, F., & Hayano, J.-I. (2004) · Chest · doi:10.1378/chest.125.2.683 · Cited by 907
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units
Van den Berghe, G., Wilmer, A., Milants, I., Wouters, P. J., Bouckaert, B., Bruyninckx, F., Bouillon, R., & Schetz, M. (2006) · Diabetes · doi:10.2337/db06-0855 · Cited by 599 · cited 2×
“The risk is similar irrespective of whether the critically ill patients received intensive or conventional insulin therapy and is not directly caused by hypoglycemia (8).”
BackgroundMaser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578 · cited 2×
“Autonomic neuropathy is a predictor of increased mortality in many diabetic cohort studies (10,11).”
BackgroundSelf-citationSchwartz, P. J., Vanoli, E., Stramba-Badiale, M., De Ferrari, G. M., Billman, G. E., & Foreman, R. D. (1988) · Circulation · doi:10.1161/01.cir.78.4.969 · Cited by 576 · cited 1×
“In addition, impairment of baroreflex sensitivity has been associated with adverse outcomes in clinical (13,14) and preclinical (26) studies.”
BackgroundBigger, J. T., Fleiss, J. L., Rolnitzky, L. M., & Steinman, R. C. (1993) · Circulation · doi:10.1161/01.cir.88.3.927 · Cited by 500
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 401
Odemuyiwa, O., Malik, M., Farrell, T., Bashir, Y., Poloniecki, J., & Camm, J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90774-f · Cited by 370 · cited 1×
“Impaired cardiac vagal control, as determined by reduced heart rate variability, is associated with increased risk of post-myocardial infarction mortality, even after adjusting for clinical, demographic, other Holter features, and ejection fraction (12;23-25).”
BackgroundTransfer function analysis of autonomic regulation. II. Respiratory sinus arrhythmia
Saul, J. P., Berger, R. D., Chen, M. H., & Cohen, R. J. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.256.1.h153 · Cited by 358
(1991) · PubMed · Cited by 245
Hepburn, D. A., Patrick, A. W., Eadington, D. W., Ewing, D. J., & Frier, B. M. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01475.x · Cited by 178
De Ferrari, G. M., Sanzo, A., Bertoletti, A., Specchia, G., Vanoli, E., & Schwartz, P. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.043 · Cited by 149 · cited 5×
“4, compared with those without impaired baroreflex sensitivity (13).”
BackgroundInfluentialBottini, P., Boschetti, E., Pampanelli, S., Ciofetta, M., Sindaco, P. D., Scionti, L., Brunetti, P., & Bolli, G. B. (1997) · Diabetes · doi:10.2337/diab.46.5.814 · Cited by 107
Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans
Ebert, T. J., & Cowley, A. W. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.5.h1372 · Cited by 104 · cited 2×
“The modified Oxford technique was used to assess cardiac vagal and sympathetic baroreflex function (17).”
BackgroundMethodMeyer, C., Grossmann, R., Mitrakou, A., Mahler, R., Veneman, T., Gerich, J., & Bretzel, R. G. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1960 · Cited by 95
Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise.
Davis, S. N., Galassetti, P., Wasserman, D. H., & Tate, D. (2000) · Diabetes · doi:10.2337/diabetes.49.1.73 · Cited by 95
Influence of Autonomic Neuropathy on QTc Interval Lengthening During Hypoglycemia in Type 1 Diabetes
Lee, S. P., Yeoh, L., Harris, N. D., Davies, C. M., Robinson, R. T. C. E., Leathard, A. D., Newman, C. M. H., Macdonald, I. A., & Heller, S. R. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1535 · Cited by 89
Automated quantification of sympathetic beat-by-beat activity, independent of signal quality
Hamner, J. W., & Taylor, J. A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1199 · Cited by 65
Fanelli, C., Pampanelli, S., Lalli, C., Sindaco, P. D., Ciofetta, M., Lepore, M., Porcellati, F., Bottini, P., Di Vincenzo, A., Brunetti, P., et al. (1997) · Diabetes · doi:10.2337/diab.46.7.1172 · Cited by 63
Rattarasarn, C., Dagogo-Jack, S., Zachwieja, J. J., & Cryer, P. E. (1994) · Diabetes · doi:10.2337/diab.43.6.809 · Cited by 59
Malik, M., & Camm, A. J. (1990) · Cardiovascular Research · doi:10.1093/cvr/24.10.793 · Cited by 54 · cited 1×
“Impaired cardiac vagal control, as determined by reduced heart rate variability, is associated with increased risk of post-myocardial infarction mortality, even after adjusting for clinical, demographic, other Holter features, and ejection fraction (12;23-25).”
BackgroundBottini, P., Boschetti, E., Pampanelli, S., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.5.814 · Cited by 23
Fanelli, C. G., Pampanelli, S., Lalli, C., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.7.1172 · Cited by 21
Kinsley, B., Widom, B., Utzschneider, K. M., & Simonson, D. C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962332 · Cited by 20
Rattarasarn, C., Dagogo-Jack, S. E., Zachwieja, J. J., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.6.809 · Cited by 15
Cited by
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
“Hypoglycaemia has a proarrhythmogenic effect through QTi prolongation, attenuation of cardiovagal baroreflex function [52], and Ca2+ overload consequent to sympathetic activation.”
BackgroundSelf-citationCryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Metadata
- Authors
- Adler, G. K., Bonyhay, I., Failing, H., Waring, E., Dotson, S., & Freeman, R.
- Affiliations
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Freeman, Roy
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 360-366
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2628609
- OpenAlex
- W2144606036
- Cited by
- 216
- References
- 33
- Citations by year
- 2025: 8 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 10 · 2020: 13 · 2019: 8 · 2018: 16 · 2017: 5 · 2016: 16 · 2015: 16 · 2014: 17 · 2013: 19 · 2012: 20
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Deutsches Krebsforschungszentrum
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063296)
- National Center for Research Resources (MO1 RR002635, M01RR002635)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Keywords
- baroreflex sensitivity, muscle sympathetic nerve activity, norepinephrine, lower body negative pressure, hyperinsulinemic hypoglycemic clamp, type 2 diabetes, tight glycemic control, cardiac autonomic dysfunction
- MeSH terms
- Adolescent, Adult, Autonomic Nervous System, Blood Glucose, Cardiovascular Diseases, Epinephrine, Heart Rate, Humans, Hypoglycemia, Male, Middle Aged, Norepinephrine, Parasympathetic Nervous System, Sympathetic Nervous System, Glucose Clamp Technique, Baroreflex, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.